Home » GENEREX BIOTECHNOLOGY AND FERTIN PHARMA ANNOUNCE METFORMIN GUM COLLABORATION
GENEREX BIOTECHNOLOGY AND FERTIN PHARMA ANNOUNCE METFORMIN GUM COLLABORATION
Generex Biotechnology Corporation, a leader in the area of buccal drug delivery, and Fertin Pharma A/S, a world leader in the development and manufacture of medicinal chewing gum, jointly announced today that they have established a collaboration for the development of a metformin medicinal chewing gum for the treatment of Type-2 diabetes mellitus and obesity.
Market Wire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May